ICU特异性虚拟现实对重症后心理健康的影响:一项国际三臂随机临床试验
这项国际三臂多中心RCT纳入344例ICU停留≥72小时且机械通气≥24小时的成人,随机分为标准治疗、早期ICU-VR(出ICU后7-15天)或晚期ICU-VR(约3个月后)。主要终点为6个月时PTSD症状严重程度(IES-R),早期与对照组无差异(β=0.32;95%CI -3.38至4.02;p=0.87),晚期与对照组也无差异(β=-0.82;95%CI -4.62至2.97;p=0.67)。焦虑、抑郁及HRQoL均无组间差异(校正p>0.05)。患者对ICU-VR的理解度和满意度评分中位数为8/10。结论不应推广至多次、治疗师引导或个性化VR干预。
要点
- 单次ICU-VR视频在6个月时未改善PTSD症状严重程度:早期vs对照β=0.32(95%CI -3.38至4.02;p=0.87),晚期vs对照β=-0.82(95%CI -4.62至2.97;p=0.67)。
- 焦虑、抑郁及健康相关生活质量(HRQoL)均无组间差异(所有校正p>0.05)。
- 患者对ICU-VR的理解度和总体满意度评分中位数为8/10,提示接受度高但未转化为临床获益。
- 结论不应推广至多次、治疗师引导或个性化VR干预;未来试验应针对高危患者、强制多次干预并个性化。
- 研究纳入ICU停留≥72小时且机械通气≥24小时的成人,6个月随访存活者随访率80%。
适用人群与场景
- 排除人群:原文未提及。
- 场景:出ICU后(早期干预在出ICU后7-15天,晚期在约3个月后的后续照护期间)。
诊断标准与关键阈值
- PTSD症状严重程度采用Impact of Event Scale-Revised(IES-R)评估,范围0-88分。
- 主要终点为6个月(T3)时PTSD症状严重程度。
- 次要终点包括焦虑/抑郁严重程度及患病率、HRQoL。
处置流程与药物剂量
- 干预为单次ICU特异性虚拟现实(ICU-VR)视频;早期组在出ICU后7-15天观看,晚期组在约3个月后的后续照护期间观看。
- 对照组接受标准治疗。
- 干预未显示对PTSD、焦虑、抑郁或HRQoL的获益,不应常规用于改善这些结局。
- 原文未提及具体药物剂量、给药途径、频次或目标值。
红旗征与不能漏的情况
- 原文未提及
研究设计与关键结果
- 干预与对照:标准治疗 vs 早期ICU-VR(出ICU后7-15天) vs 晚期ICU-VR(约3个月后),随机比例1:1:1。
- 主要终点:6个月时PTSD症状严重程度(IES-R)早期ICU-VR与对照无差异(β=0.32;95%CI -3.38至4.02;p=0.87),晚期ICU-VR与对照无差异(β=-0.82;95%CI -4.62至2.97;p=0.67)。
- 关键次要终点:焦虑、抑郁、HRQoL均无组间差异(所有校正p>0.05)。
- 患者对ICU-VR的理解度和总体满意度评分中位数为8/10。
证据类型、等级与局限
- 证据类型:随机对照试验(RCT)。
- 证据等级或推荐强度:原文未提及。
- 局限:单次ICU-VR视频干预;结论不应推广至多次、治疗师引导或个性化VR干预;未来试验应针对高危患者、强制多次干预并个性化。
对床旁实践的改变
- 不改变现有实践:单次ICU-VR视频不应作为改善重症幸存者6个月PTSD、焦虑、抑郁或HRQoL的常规干预。
- 适用人群:ICU停留≥72小时且机械通气≥24小时的成人重症幸存者;不适用于原文未提及的人群。
- 常见陷阱:不应将本试验结果外推至多次、治疗师引导或个性化VR干预;患者满意度高(中位数8/10)不代表临床结局改善。
指南或共识出处
- 原文未提及指南或共识名称;试验注册:Netherlands Trial Register/International Clinical Trials Registry Platform,NL9812,2021年10月21日。
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Survivors of critical illness frequently experience symptoms of post-intensive care syndrome (PICS), including post-traumatic stress disorder (PTSD), anxiety, and depression, with downstream impact on health-related quality of life (HRQoL). We evaluated whether an intensive care unit-specific virtual reality (ICU-VR) video improves mental health outcomes and whether timing (early vs. late) matters.
METHODS: We conducted an international, three-arm, multicentre randomized clinical trial across eleven hospitals. Adults (≥ 18 years) with ICU stay ≥ 72 h and mechanical ventilation ≥ 24 h were randomized 1:1:1 to (1) standard care, (2) early ICU-VR (within 7-15 days post-ICU), or (3) late ICU-VR (≈ 3 months, during aftercare). The primary endpoint was PTSD symptom severity at six months (T3) measured by the Impact of Event Scale-Revised (range 0-88). Secondary endpoints included anxiety/depression severity and prevalence, and HRQoL.
RESULTS: We randomized 344 participants (median age 61 years; 62% male); follow-up among survivors at six months (T3) was 80%. At six months, PTSD symptom severity did not differ between early ICU-VR and control (β = 0.32; 95% CI -3.38 to 4.02; p = 0.87) nor late ICU-VR and control (-0.82; 95% CI -4.62 to 2.97; p = 0.67). No between-group differences were observed for anxiety, depression, or HRQoL (all adjusted p > 0.05). Patients rated ICU-VR highly for improving understanding of the ICU experience and overall satisfaction (median 8/10).
CONCLUSIONS: In this multicentre randomized clinical trial, a single ICU-VR video did not improve PTSD, anxiety, depression, or HRQoL at six months versus standard care. Findings should not be generalized to multi-session, therapist-guided, or personalized VR interventions. Future trials should target high-risk patients, make multi-session mandatory, and personalize ICU-VR.
TRIAL REGISTRATION: This study was prospectively registered Netherlands: Trial Register/International Clinical Trials Registry Platform, NL9812, October 21, 2021.
参考来源
- Drop DLQ, Vlake JH, van Bommel J, et al. ICU-specific virtual reality for mental health after critical illness: an international three-arm randomized clinical trial. Crit Care. 2026. PMID: 42638131. doi:10.1186/s13054-026-06186-4
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。